Tumor regression grading after preoperative chemoradiotherapy as prognostic factor and individual-level surrogate for disease-free survival in rectal cancer: Results of the CAO/ARO/AIO-04 multicentre, open-label, randomised, phase 3 trial - Fokas, E.; Stroebel, P.; Fietkau, Rainer; Ghadimi, M.; Liersch, T.; Grabenbauer, G.; Hartmann, Arndt; Kaufmann, M.; Sauer, Rolf; Graeven, U.; Hoffmanns, H.; Raab, H-R; et al. (2017)
EVALuna2:32881